Essays on Anti-Cancer

Ontario’s HPV Vaccination Program

In this paper, I present arguments that are supportive of the ethical inappropriateness of the Ontario government’s HPV vaccination initiative. I also aim at revealing the ineffectiveness of the program as a public health strategy constructed to combat cervical cancer. In addition, I will use the utilitarian approach to support my views.

The Ontario HPV Program Overview

In September 2007, the Ontario Liberal Government began a Human Papilloma Virus (HPV) vaccination intervention for female eighth-graders (Thompson, 2013; CIHR- IPPH, 2012). The federal government made an allocation of $ 300 million towards the intervention. Gardasil, the HPV vaccine, targets four subtypes of the virus. These ...

A healthy diet can make huge differences in helping a person suffering from any disease, especially cancer or heart disease. There are some foods that contribute to the development of cancer and others help to prevent it. The same phenomenon goes with the heart disease as well. Scientists have discovered that eating more fruits and vegetables can lower the risk of cancer in the body but they are not sure for the specific nutrients that are helpful in lowering down the risk. Studies have shown that Mediterranean diet can help prevent cancer and eating of foods like fish, beans, ...

A second-generation drug is a drug that is designed to target a patient’s molecules that have defects. These defects may include cancerous cells in the body of a patient. Cancer growth in the human body is the unregulated or uncontrolled growth of cells with metastasis and usually this growth spreads to the other organs and tissues of the body. The second-generation drug targets the cells that are continuously reproducing and thus prevent the cells from continuously reproducing uncontrollably. The clinical candidate tipifarnib is a second-generation drug that targets the causative agent of the chagas disease. - Protozoan parasite, Trypanosoma cruzi (T. ...

The product opportunity is based on the consistent on awareness on different types of cancer with a global date set to create global awareness annually. The awareness programs and campaigns are largely aimed at advocating need for testing among patients for early diagnosis in relation to creating a cancer free environment. However, the fact that those diagnosed are offered a new chance to fight the disease indicates the essence of chemotherapy drugs to facilitate full recovery of these patients. The significant problems that Chemotherapeutic Anti-cancer agents are likely to solve due to the compounds that it possess with potent activity within ...

Abstract

The primary aim of anticancer therapies is to induce the death of tumor cells. Cisplatin has done a good job in achieving this aim, which explains why it is the most commonly used adjuvant therapy of cancers. However, the success of applying CDDP and any other platinum compounds for cancer chemotherapy depends enormously on the ability to manage its side effects. This paper reviews the studies and literatures on cisplatin and some other similar platinum compounds. It presents its history and background, chemistry, mechanism of activity, as well as the side effects.

Introduction

The cisplatin has been described as a tiny little ...

Objectives.4

Bristol-Myers Squibb5 Mission and Vision Statement..7 Business Strategy..7 Technology Management..9

Pharmaceutical Development9

Technology Strategy for Improvement11 Conclusion12 Recommendation13

References14

Technology Management at Bristol-Myers Squibb Introduction In the world of biopharmaceuticals corporations have to compete with global companies in providing the best medicine in order to help treat illness around the world. The healthcare sector around the world operates in a unique, complex social, ethical, and political environment in which the main priorities of equity are achieved through various means. Bristol-Myers Squibb (BMS) is a global biopharmaceutical company that discovers and delivers the most innovative medicine to help ...

Introduction

Antigen Presentation Antigen presentation plays a pivotal role in the immune system through which pathogenic antigens are processed and coupled along with major histocompatibility complex (MHC), and presented to T cells for their effector response. Macrophages, B cells and dendritic cells are the primary antigen presenting cells (APC’s). Intracellular antigens generated by viruses, or some cytoplasmic bacterial antigens are digested by the host cells and coupled with MHC Class I by Transporter associated with antigen Processing complex (TAP), which transports them to the cell surface and presents to CD8+ cytotoxic T cells (Germain, R 1994). These cells elicit a ...

Targeted therapies that include small molecule inhibitors and monoclonal antibodies have considerably altered the cancer treatment over the past several years. These drugs are currently a part of therapy for several widespread malignancies, including colorectal, breast, pancreatic, and lung cancers, as well as leukemia, multiple myeloma, and lymphoma. The action mechanisms, as well as toxicities of targeted therapies, are different from the action mechanisms of traditional cytotoxic chemotherapy. Targeted therapies are usually better endured than traditional chemotherapy, although they are linked to a number of unfavorable effects, like cardiac dysfunction, acneiform rash, proteinuria, thrombosis, and hypertension. Small molecule inhibitors are acted ...